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Introduction
Naphthoquinone is a class of  phenolic compounds 
derived from naphthalene occurring to some extent 
in fungi and are extremely common in higher plants 
and contain the naphthalene nucleus with two 
carbonyl groups on one nucleus usually at the ortho 
or para position (bicyclic). Naphthoquinones are 
widely distributed in plants, fungi and some animals 
and many were found to exhibit interesting range of  
pharmacological properties such as antibacterial1,2, 
antiviral3, trypanocidal4, anticancer5, antimalarial6,7 and 
antifungal8 activities. Other quinone-related scaffolds 
such as 2-H-pyran-3(6H)-one derivatives8 and 2,3-
dideoxyhexenopyranosides9 are also known for their 
biological activities against Staphylococcus species 
and Mycobacterium tuberculosis. Interestingly, 7-MJ, 
a naphthoquinone exhibits most of  these activities. 
Therefore, we undertook the present review to bring out 
pharmacological knowledge on 7-MJ. We also discussed 
herein the biosynthesis and the in vitro synthesis of  this 
compound.
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Methods
The chemical and pharmacological data were collected 
from the well-known scientific websites such as Pubmed, 
Google Scholar, Scirus, Scopus, Sciencedirect, Reaxys, 
Web-of-knowledge and Scifinder. The chemical names, 
7-methyjulglone, ramentaceone or 6-Methyl-8-hydroxy-
1,4-naphthoquinone or 5-Hydroxy-7-methyl-1,4-naph-
thoquinone or 7-Methyl-5-hydroxy-1,4-naphthoqui-
none or 5-Hydroxy-7-methyll-,1,4-naphtoquinoneor 
7-Methyl-5-hydroxynaphthalene-1,4-dione were used 
as key word in the above websites and all relevant re-
search papers were retrieved. The collected documents 
served as necessary tools and were analyzed for data 
collection. 
Results 
The naphthoguinone 7-MG has been isolated from 
different parts of  the plants of  the family Ebenaceae; 
This includes the bark of  Diospyros maritima10, the twigs 
of  Diospyros lycioides  Desf.11, the roots of  Diospyros 
lotus L.12, Euclea natalensisA.DC.13, Euclea undulata14 
and Diospyros virginiana.15 7-MG (Fig. 1) appeared 
as an orange needles [m.p. 150-152°C,11 or 155°C16 or 
156°C, or yellow needles; mp. 126°C; density 1.371g/
cm3 ; boiling point: 427.2°C at 760 mmHg ; refractive 
index: 1.642]. IR(KBr, cm-1): 1670, 1645 (C=O); δH 
(CDCl3, 200 MHz); 11.84 (1H, s, 5-OH), 7.42 (1H, s, 
H-8), 7.06 (1H, s, H-6), 6.89 (2H, s, H-2, H-3), 2.41 
(3H, s, CH3); found: (EI) 188.0475, C11H8O3 requires 
188.0473.17
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Fig.1. Chemical structure of  7-methyljuglone (7-MJ)
Biosynthesis and in vitro synthesis
It has been shown that higher plants have developed 
at least three separate pathways for the synthesis of  
the naphthoquinone carbon skeleton, including the 
shikimate, the homogentisate and the polyacetate-
malonate pathways. The two main ways of  
naphthoquinones biosynthesis in higher plants include 
direct incorporation of  shikimate17 or the homogentisic 
acid pathway involving the condensation of  mevalonic 
acid and most probably toluhydroquinone17. It was 
demonstrated that 2-Methyl-juglone (plumbagin) by its 
striking structural similarity with juglone and menadion 
was expected to be formed via the shikimate pathway, by 
C-methylation of  Juglone in the 2 position18. According 
to Durand and Zenk19 plumbagin and 7-MJ are the first 
napthoquinones in higher plants shown to be formed 
according to the acetate pathway which has long been 
known for the formation of  naphthoquinones in 
fungi20. An hexaacetyl chain leads to the formation of  
these naphthalenes19. 
The synthesis of  7-MJ was realized by Mahapatra21 
as follows: A mixture of  anhydrous AlCl3 (40 g, 300 
mmol) and NaCl (8 g, 137 mmol) were heated to 180ºC. 
A mixture of  appropriate 4-halo-3-methyl phenol (10.7 
mmol) or 4-halo-2-methyl phenol and maleicanhydride 
(4 g, 40.8 mmol) was added to the above melt with 
vigorous stirring for 2 min, and then poured into a 
mixture of  ice and 12 M HCl. The mixture was kept 
for 30 min, and the precipitate was filtered and dried at 
room temperature overnight. The residue obtained was 
powdered and extracted with n-hexane with vigorous 
stirring at 50ºC. The extract was concentrated under 
reduced pressure and crystallized from chloroform to 
afford the halogenated products 2-5. A solution of  3 
(200 mg, 0.90 mmol) in THF (20 mL) was added drop-
wise to a solution of  SnCl2 (1.0 g, 51 mmol) in 4 M HCl 
(70 mL) and THF (20 mL) at 60 ºC and stirred for 3 h. 
It was then cooled and filtered into a solution of  FeCl3. 
The resulting precipitate was filtered and dried to afford 
7-MJ (Fig. 2).
 Fig.2. Synthesis of  7-methyljugulone. Reagents and conditions: (i) maleic anhydride, AlCl3, NaCl, 180°C, 2 min; 




















Naphthoquinone X R1 R2 R3
2 F Me H OH
3 Cl Me H OH
4 Br Me H OH
5 Cl H Me OH
6 H H Me OH
1 (7-MJ) H Me H OH
The antifungal activities of  7-MJ were reported 
against Cryptococcus neoformans [50% inhibition 
of  growth concentration (GI50) of  0.3 µg/mL and a 
Minimal Inhibitory Concentration (MIC) of  1 µg/mL], 
Candida albicans  (GI50: 0.3 µg/mL; MIC: 20 µg/mL), 
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Saccharomyces cerevisiae (GI50: 0.3 µg/mL; MIC: 1 µg/
mL) and Aspergillus niger (GI50: 5 µg/mL; MIC: 300 µg/
mL).10  7-MJ also displayed antifungal activities against 
Phomopsis obscurans [inhibition percentage (IP) of  
97%] and Phomopsis viticola (IP of  53.4 - 54.3%) at 
202
African Health sciences Vol 14 No. 1 March 2014
30 µM.15
7-MJ also demonstrated inhibitory activities against the 
Gram-positive oral streptococci, Streptococcus mutans 
(MIC of  156 µg/mL) and S. sanguis (MIC: 78 µg/mL) 
as well as against the Gram-negative anaerobic rods 
Prevotella gingivalis (MIC: 39 µg/mL) and P. intermedia 
(MIC: 78 µg/mL) frequently associated with human 
peritonitis known as gum disease.11 The antibacterial 
activity of  this compound was also reported against M. 
luteus  (GI50: 20 µg/mL; MIC: 1000 µg/mL).
10  
7-MJ showed an exceptional antitubercular inhibitory 
effects against Mycobacterium tuberculosis H37Rv 
with a MIC value of  0.5 µg/mL combined to a very 
good selectivity index of  30.22 on normal vero cells.21 
This compound was found to react as potent subversive 
substrate for the NADPH-dependent enzyme 
mycothiol disulfide reductase of  M. tuberculosis, 
which is one of  several potential biological targets for 
it anti-mycobacterial activity17. In fact, M. tuberculosis 
lacks glutathione, instead it maintains millimolar 
concentrations of  the structurally distinct low 
molecular weight thiol mycothiol (MSH).17 Analogous 
to glutathione, MSH plays an important role in oxidative 
stress management and is oxidized to the symmetrical 
disulfide (MSSM) in the process. The NADPH-
dependent enzyme mycothiol disulfide reductase (Mtr)22 
helps to maintain an intracellular reducing environment 
by reducing MSSM back to MSH. MSH is essential for 
the growth of  M. tuberculosis23 and MSH-deficient 
mycobacteria exhibit increased sensitivity to oxidative 
stress making this redox pathway a potential biological 
target for novel antitubercular chemotherapies.21 7-MJ 
also showed a very good antimycobacterial activity on 
other mycobacteria, with MIC values as low as 1.55 µg/
mL against M. bovis, 1.57 µg/mL against M. smegmatis 
and 1.55 µg/mL on M. fortuitum.14 A 50% inhibition 
of  growth concentration was also reported to be 5 µg/
mL against M. avium.10  
7-MJ displayed antiviral activities through the inhibition 
of  recombinant reverse transcriptase of  HIV-1 with 80 
to 100% inhibition at the concentration ranges of  12.5 
to 100 μg/mL.24 This phytochemical also inhibited the 
human rhinovirus 3C protease with an IC50 value of  6.4 
μM.25   
The cytotoxicity of  7-MJ was reported on several cancer 
cell lines including human oral epidermoid carcinoma 
[KB (IC50 value of  4.1 µM)], the human lung cancer cells 
[Lu1 (IC50: 13.2 µM)] and hormone-dependent human 
prostate cancer cells [LNCaP] (IC50: 3.7 µM).
10 Though 
this compound was less toxic against the normal monkey 
kidney vero cells21, its toxicity toward the Umbilical 
Vein Endothelial Cells (HUVEC) was rather found to 
be higher (IC50: 5.7 µM) clearly indicating that possible 
chemotherapy involving pregnant women should be 
taken with caution. At 10 µM, 7-MJ induced apoptosis 
against leukemia HL60 cells with the percentage of  
Sub-G1 phase ranged from 10.3 - 27.5% whilst the IC50 
value of  8.75 µM was reported on this cell line.26 
Discussion
7-MJ was isolated mostly in the family Moraceae. 
especially in the genus Diospyros and Euclea. The 
occurrence of  naphthoquinones in the two genera has 
been documented10-15. Its partial synthesis has also been 
described21, suggesting that the compounds can easily 
be available for any in vivo and possible clinical studies. 
Phytochemicals are routinely classified as antimicrobials 
on the basis of  susceptibility tests that produce MIC in 
the range of  100 to 1000 mg/mL27. Activity is considered 
to be significant if  MIC values are below 10 μg/mL 
for pure compound, moderate when 10<MIC<100 
μg/mL and low when the MIC values is above 100 
µg/mL28,29. On this basis, 7-MJ can be considered as 
significantly effective antimicrobial compound against 
Saccharomyces cerevisiae (MIC: 1 µg/mL)10, M. bovis 
(1.55 µg/mL), M. smegmatis (1.57 µg/mL) and  M. 
fortuitum (1.55 µg/mL) 14. This clearly shows that this 
compounds can be explored more as potential drug 
against some pathogenic fungi and bacteria. In the 
US NCI screening program, a compound is generally 
considered to have in vitro cytotoxic activity, if  the IC50 
value following incubation between 48 and 72 h, is less 
than 4 µg/ml or 10 μM30. 
On this basis, 7-MJ can also be considered as a good 
cytotoxic compound against several cancer cell lines 
such as KB, Lu1 and LNCaP10. Its selectivity toward 
cancer cells as compared with the normal vero monkey 
kidney cells 17 suggests that this compound is relatively 
safe for a potential anticancer treatment. Nevertheless, 
its toxicity toward the HUVEC indicated that caution 
should be taken when a potential treatment involve a 
pregnant women. 
Conclusion
The present review obviously showed that 7-MJ could 
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move forward into in vivo studies, in regards to its 
enormous pharmacological activities. Also, the study 
of  the possible drug-drug interaction of  7-MJ is to be 
investigated. However, 7-MJ displayed high toxicity in 
HUVEC cells, clearly indicating that caution should 
be taken for any treatment involving pregnant women. 
The easy way of  the in vitro chemical synthesis of  7-MJ 
ensure the availability of  the compound for necessary 
future studies. Finally, the present work can served as 
a the future starting point for the developments of  
pharmaceutical from this potentially potent biological 
molecule.
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